Journal of Clinical Oncology, Vol 20, Issue 4
(February), 2002: 921-929
© 2002 American Society for Clinical Oncology
Novel Artificial Neural Network for Early Detection of Prostate Cancer
By Bob Djavan,
Mesut Remzi,
Alexandre Zlotta,
Christian Seitz,
Peter Snow,
Michael Marberger
From the Department of Urology, University of Vienna, Austria; Department of Urology, Erasme University Clinics of Brussels, Belgium; and Xaim, Inc, Colorado Springs, CO.
Address reprint requests to Bob Djavan, MD, PhD, Department of Urology, University of Vienna, Wahringer Gurtel 18-20, A-1090 Vienna, Austria; email: bdjavan{at}hotmail.com
PURPOSE: Two artificial neural networks (ANN) for the early detection of prostate cancer in men with total prostate-specific antigen (PSA) levels from 2.5 to 4 ng/mL and from 4 to 10 ng/mL were prospectively developed. The predictive accuracy of the ANN was compared with that obtained by use of conventional statistical analysis of standard PSA parameters.
PATIENTS AND METHODS: Consecutive men with a serum total PSA level between 4 and 10 ng/mL (n = 974) and between 2.5 and 4 ng/mL (n = 272) were analyzed. A separate ANN model was developed for each group of patients. Analyses were performed to determine the presence of prostate cancer.
RESULTS: The area under the receiver operator characteristic (ROC) curve (AUC) was 87.6% and 91.3% for the 2.5 to 4 ng/mL and 4 to 10 ng/mL ANN models, respectively. For the latter model, the AUC generated by the ANN was significantly higher than that produced by the single variables of total PSA, percentage of free PSA, PSA density of the transition zone (TZ), and TZ volume (P < .01), but not significantly higher compared with multivariate analysis. For the 2.5 to 4 ng/mL model, the AUC of the ANN ROC curve was significantly higher than the AUCs for percentage of free PSA (P = .0239), PSA-TZ (P = .0204), and PSA density and total prostate volume (P < .01 for both).
CONCLUSION: The predictive accuracy of the ANN was superior to that of conventional PSA parameters. ANN models might change the way patients referred for early prostate cancer detection are counseled regarding the need for prostate biopsy.
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
C. STEPHAN, H. RITTENHOUSE, H. CAMMANN, M. LEIN, M. SCHRADER, S. DEGER, K. MILLER, and K. JUNG
New Markers and Multivariate Models for Prostate Cancer Detection
Anticancer Res,
July 1, 2009;
29(7):
2589 - 2600.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. J. Lee, K. G. Kim, S. E. Lee, S.-S. Byun, S. I. Hwang, S. I. Jung, S. K. Hong, and S. H. Kim
Role of transrectal ultrasonography in the prediction of prostate cancer: artificial neural network analysis.
J. Ultrasound Med.,
July 1, 2006;
25(7):
815 - 821.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Garzotto, T. M. Beer, R. G. Hudson, L. Peters, Y.-C. Hsieh, E. Barrera, T. Klein, and M. Mori
Improved Detection of Prostate Cancer Using Classification and Regression Tree Analysis
J. Clin. Oncol.,
July 1, 2005;
23(19):
4322 - 4329.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Matsui, N. Utsunomiya, K. Ichioka, N. Ueda, K. Yoshimura, A. Terai, and Y. Arai
The Use of Artificial Neural Network Analysis to Improve the Predictive Accuracy of Prostate Biopsy in the Japanese Population
Jpn. J. Clin. Oncol.,
October 1, 2004;
34(10):
602 - 607.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Stephan, H. Cammann, A. Semjonow, E. P. Diamandis, L. F.A. Wymenga, M. Lein, P. Sinha, S. A. Loening, and K. Jung
Multicenter Evaluation of an Artificial Neural Network to Increase the Prostate Cancer Detection Rate and Reduce Unnecessary Biopsies
Clin. Chem.,
August 1, 2002;
48(8):
1279 - 1287.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kattan
Statistical Prediction Models, Artificial Neural Networks, and the Sophism "I Am a Patient, Not a Statistic"
J. Clin. Oncol.,
February 15, 2002;
20(4):
885 - 887.
[Full Text]
[PDF]
|
|
|
|
